We have characterized the in vitro and in vivo characteristics of human adipose-derived mesenchymal stem cells (A-MSC), and compared them to marrow MSC (BM-MSC). We learned that MSC lodge at low levels into multiple tissues in immune deficient mice, but that both BM-MSC and A-MSC migrate from the bloodstream into areas of hypoxic tissue damage much more robustly, and we are continuing to define the mechanisms involved. We have dissected putative markers and phenotypes, and learned that surface proteins are altered dependent upon microenvironmental factors such as oxygen concentration and ligand binding. Our hypothesis is that the """"""""tissue-repairing subset"""""""" of MSC is composed of highly adaptable cells that are poised to respond rapidly to the wound or inflammatory microenvironment by altering cell surface receptor expression, integrins, MMPS, and other proteins related to migration, retention, and survival. MSC are """"""""paramedics"""""""", navigating through tissue to secrete paracrine factors that initiate cascades of endogenous repair and revascularization. It is beneficial if they are able to respond to the environment and to adapt very rapidly. But, this quality makes it difficult to prospectively isolate MSC for tissue repair. Thus, the phenotype of the most primitive MSC compartment, to allow prospective isolation from marrow or adipose tissue, is still not well defined and remains a goal of the grant application. We hypothesize that standard MSC culture conditions, which are non-physiological, are differentiating MSC to states that are not compatible with maximal tissue repair capacity. The goal of the current grant, reduced in scope is to subfractionate and to continue to examine MSC phenotype, in standard culture and in more physiological conditions, with the goal of prospectively isolating and potentially expanding primitive populations which retain the ability to form cartilage, bone, and fat and/or to home to damaged tissues. We will compare the phenotype and function of MSC expanded under standard conditions to more physiologic conditions, in comparison to prospectively isolated ALDH hi/CD45-/CD31-MSC populations. We will use clonal integration marking and novel xenotransplantation models to define conditions that allow recruitment of the highest numbers of primitive human MSC to areas of tissue damage, and to better define multipotency and self-renewal in this interesting adult stem cell population.

Public Health Relevance

Adult mesenchymal stem cells are fascinating cells that can be isolated and expanded from human bone marrow or fat, and returned to a patient to revascularize and repair tissues following injury such as heart attack or peripheral vascular disease. They do not actually become the tissue, but act as catalysts to start cascades of repair and regeneration within the tissue. We have developed novel models which allow investigation into the biology and the tissue homing capabilities of MSC, and our goal is to gain a better understanding of the mechanisms involved with cell survival, migration, and tissue repair, in order to make therapies more robust. Strategies to prospectively isolate MSC from a tissue isolate, for immediate return to an injured patient in an acute injury setting, are still very much needed, and that is one goal of this proposal, in addition to gaining a better understanding of the phenotype, function, biology, and regenerative capacity of these interesting cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL073256-06
Application #
7905169
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Thomas, John
Project Start
2009-07-20
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
6
Fiscal Year
2010
Total Cost
$382,500
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Jung, Yunjoon; Nolta, Jan A (2016) BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells. Curr Stem Cell Res Ther 11:131-40
Annett, Geralyn; Bauer, Gerhard; Nolta, Jan A (2013) Mesenchymal stem cells for trinucleotide repeat disorders. Methods Mol Biol 1010:79-91
Olson, Scott D; Pollock, Kari; Kambal, Amal et al. (2012) Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol 45:87-98
Jung, Yunjoon; Bauer, Gerhard; Nolta, Jan A (2012) Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30:42-7
Olson, Scott D; Kambal, Amal; Pollock, Kari et al. (2012) Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Mol Cell Neurosci 49:271-81
Fierro, Fernando A; Kalomoiris, Stefanos; Sondergaard, Claus S et al. (2011) Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 29:1727-37
Gruenloh, William; Kambal, Amal; Sondergaard, Claus et al. (2011) Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 17:1517-25
Zhou, Ping; Lessa, Nataly; Estrada, Daniel C et al. (2011) Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl 17:418-27
Rosova, Ivana; Link, Daniel; Nolta, Jan A (2010) shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair. Tissue Eng Part A 16:2627-39
Sondergaard, Claus S; Hess, David A; Maxwell, Dustin J et al. (2010) Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med 8:24

Showing the most recent 10 out of 29 publications